Bloomberg the Company & Products

Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us

  • Exchange: Tokyo
  • Sector: Health Care
  • Industry: Biotech & Pharma
  • Sub-Industry: Specialty Pharma

Rohto Pharmaceutical Co Ltd

+ Add to Watchlist

4527:JP

1,717.0 JPY 6.0 0.35%

As of 02:00:00 ET on 03/27/2015.

Snapshot for Rohto Pharmaceutical Co Ltd (4527)

Open: 1,694.0 Day's Range: 1,656.0 - 1,731.0 Volume: 699,000
Previous Close: 1,711.0 52wk Range: 1,341.0 - 1,872.0 1-Yr Rtn: -3.84%

Stock Chart for 4527

No chart data available.
  • 4527:JP 1,716.0
  • 1D
  • 1M
  • 1Y
1,711.0
Interactive 4527 Chart

Previous Close

No chart data available.
Interactive Chart
  • 1D
  • 1W
  • 1M
  • YTD
  • 1Y
  • 3Y
  • 5Y
Close:
Open:
High:
Low:
Volume:
Recently Viewed Symbols
Save as Watchlist
Saving as watchlist...

Key Statistics for 4527

Current P/E Ratio (ttm) 29.4865
Estimated P/E(03/2015) 20.7970
Relative P/E vs. TPX 1.6487
Earnings Per Share (JPY) (ttm) 58.2300
Est. EPS (JPY) (03/2015) 82.5600
Est. PEG Ratio -
Market Cap (M JPY) 202,484.52
Shares Outstanding (M) 117.93
30 Day Average Volume 720,590
Price/Book (mrq) 1.8351
Price/Sale (ttm) 1.3159
Dividend Indicated Gross Yield 1.11%
Cash Dividend (JPY) 10.0000
Dividend Ex-Date 03/27/2015
5 Year Dividend Growth 6.30%
Next Earnings Announcement 05/14/2015
mrq = Most Recent Quarter; ttm = Trailing Twelve Months

Income Statement for 4527

  • Revenue
  • Net Income (M/JPY)
  • Profit Margin (%)

Company Profile & Key Executives for 4527

ROHTO PHARMACEUTICAL CO., LTD. manufactures and markets pharmaceuticals and cosmetics products. The Company's products include eyewash, bath soaps, gastrointestinal medicine, and hand cream. Rohto Pharmaceutical also has a license agreement with its subsidiary, Mentholatum (US) to sell their brand products. The Company also manufactures contact lenses and health foods.

Kunio YamadaChairman/CEOToshiaki YoshinoPresident/COO
Akiyoshi YoshidaExecutive Vice PresidentLekh Raj JunejaExecutive Vice President
More Company Profile & Key Executives for 4527

Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.

Sponsored Link
Advertisement
Advertisement
Sponsored Links
Advertisements
sec ||= nil